Hims & Hers Health, Inc. reported a strong third quarter in 2024 with revenue of $401.6 million, up 77% year-over-year. The company achieved a net income of $75.6 million and Adjusted EBITDA of $51.1 million. Subscriber base grew to 2.0 million, a 44% increase year-over-year. The company also raised its full year 2024 revenue guidance to a range of $1.460 billion to $1.465 billion and Adjusted EBITDA guidance to a range of $173 million to $178 million.
Revenue increased by 77% year-over-year, reaching $401.6 million in Q3 2024.
Net income was $75.6 million, including a $60.8 million tax benefit.
Adjusted EBITDA was $51.1 million, compared to $12.3 million in the same quarter last year.
The subscriber base grew to 2.0 million, reflecting a 44% year-over-year increase.
Hims & Hers provided revenue and Adjusted EBITDA guidance for Q4 2024 and full year 2024.
Visualization of income flow from segment revenue to net income
Analyze how earnings announcements historically affect stock price performance